Fund moves
353KShares reported
37 tracked managers disclosed the same change for Q2 2025. Among this manager's largest new positions for Q2 2025.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jun 24, 2025 · Filed Jun 25, 2025
A Rocket Lab director sold $134K of Rocket Lab shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$134,346
Shares × reported transaction price
47 days after results of May 8, 2025, 44 days before results of Aug 7, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Feb 27, 2025 in the U.S. District Court, C.D. California. A filing is an allegation, not a finding.
Douglas Bray v. Rocket Lab USA, Inc., docket 2:25-cv-01733, via CourtListener (court records). Nature of suit 850, company named as first defendant
Fund moves
37 tracked managers disclosed the same change for Q2 2025. Among this manager's largest new positions for Q2 2025.
Merline Saintil (Director) sold ~$78K of Rocket Lab
Planned saleMerline Saintil (Director) sold ~$49K of Rocket Lab
Planned saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.